Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

Clinical trial NCT03600233 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03600233
Sponsor: TaiRx, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors Pancreatic Neuroendocrine Tumor Gastro-enteropancreatic Neuroendocrine Tumor Lung Neuroendocrine Neoplasm Neuroendocrine Carcinoma

Start date: 2018-12-15
Primary completion: 2024-09-30
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.